GLYCIPEN GLARITUS

How GLYCIPEN GLARITUS Works

• GLYCIPEN GLARITUS is a combination medication designed to manage blood sugar levels in individuals with type 2 diabetes. It combines two active ingredients: a rapid-acting insulin analog (Glaritus) and a GLP-1 receptor agonist (GLYCIPEN). Each component works through distinct mechanisms to achieve comprehensive glycemic control.
• Glaritus, a long-acting insulin analog, provides a basal level of insulin throughout the day. It mimics the natural, continuous release of insulin from the pancreas. By providing a stable background insulin level, Glaritus helps to regulate blood sugar levels between meals and during sleep. It works by binding to insulin receptors on cells, allowing glucose to enter cells for energy production or storage. This process lowers blood glucose levels, contributing to overall glycemic control. The prolonged action of Glaritus helps to reduce the risk of both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) overnight and between meals.
• GLYCIPEN, a GLP-1 receptor agonist, complements the action of Glaritus by targeting different aspects of glucose regulation. GLYCIPEN works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a natural hormone that is released from the gut in response to food intake. When GLYCIPEN binds to GLP-1 receptors, it stimulates insulin release from the pancreas in a glucose-dependent manner. This means that insulin is released only when blood sugar levels are elevated, reducing the risk of hypoglycemia. GLYCIPEN also suppresses glucagon secretion, a hormone that raises blood sugar levels. By inhibiting glucagon, GLYCIPEN further contributes to lower post-meal glucose excursions. Beyond its effects on insulin and glucagon, GLYCIPEN also slows down gastric emptying, which can help to reduce postprandial glucose spikes and promote a feeling of fullness, potentially aiding in weight management.
• The synergistic action of Glaritus and GLYCIPEN provides comprehensive glycemic control by addressing both basal and postprandial glucose levels. Glaritus provides a steady background insulin level, while GLYCIPEN enhances insulin secretion in response to meals and suppresses glucagon release. This combination helps to maintain stable blood sugar levels throughout the day and night, reducing the risk of both hyperglycemic and hypoglycemic events. Additionally, the weight management benefits of GLYCIPEN can be particularly advantageous for individuals with type 2 diabetes, as obesity often contributes to insulin resistance and poor glycemic control. GLYCIPEN GLARITUS is an effective medication to treat type 2 Diabetes Mellitus.

Like all medicines, GLYCIPEN GLARITUS can cause side effects, although not everybody gets them. **Common side effects (may affect up to 1 in 10 people):** * Hypoglycemia (low blood sugar): This is the most common side effect. Symptoms can include: sweating, shakiness, anxiety, blurred vision, rapid heartbeat, dizziness, headache, hunger, confusion, irritability, difficulty concentrating, slurred speech, and numbness around the mouth. *Severe hypoglycemia can lead to unconsciousness and, in very rare cases, be fatal.* * Injection site reactions: Redness, swelling, itching, or pain at the injection site. * Lipohypertrophy: Thickening of the skin at the injection site. * Weight gain * Allergic reactions: Skin rash and itching **Uncommon side effects (may affect up to 1 in 100 people):** * Peripheral neuropathy (nerve damage): Causing pain, burning, tingling, or numbness in the hands and feet. * Edema (swelling): Swelling in the ankles and feet due to fluid retention. **Rare side effects (may affect up to 1 in 1,000 people):** * Severe allergic reactions: Including difficulty breathing, wheezing, rapid heartbeat, sweating, and feeling faint. * Visual disturbances: Changes in vision. **Very rare side effects (may affect up to 1 in 10,000 people):** * Taste disturbances * Myalgia (muscle pain) **Other possible side effects (frequency not known):** * Skin changes at the injection site (e.g., amyloidosis cutis).

• If you miss a dose of GLYCIPEN GLARITUS, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

• Keep GLYCIPEN (GLARITUS) away from the reach of children and pets.
• Store GLYCIPEN (GLARITUS) at room temperature.

• **Consistency is Key:** Administer GLYCIPEN GLARITUS at the same time each day to maintain stable blood sugar levels. Establishing a routine helps your body utilize insulin effectively.
• **Proper Injection Technique:** Always inject GLYCIPEN GLARITUS subcutaneously (under the skin) as instructed by your healthcare provider. Rotate injection sites to prevent lipohypertrophy (thickening of the skin) which can affect insulin absorption. Common sites include the abdomen, thigh, and upper arm. Clean the area with an alcohol swab before injecting.
• **Monitor Blood Sugar Regularly:** Regularly monitor your blood sugar levels as directed by your doctor. This helps you understand how GLYCIPEN GLARITUS is working for you and allows for dosage adjustments if needed. Keep a log of your blood sugar readings to share with your healthcare team.
• **Diet and Exercise Matters:** Combine GLYCIPEN GLARITUS with a healthy diet and regular exercise. A balanced meal plan and physical activity can significantly improve blood sugar control and overall well-being. Consult with a registered dietitian or certified diabetes educator for personalized guidance.
• **Recognize and Treat Hypoglycemia:** Be aware of the symptoms of hypoglycemia (low blood sugar), such as sweating, shakiness, confusion, and dizziness. Carry a readily available source of glucose, such as glucose tablets or juice, to treat low blood sugar immediately. Inform family members and close contacts about how to recognize and treat hypoglycemia.
• **Storage is Important:** Store GLYCIPEN GLARITUS in the refrigerator (2°C to 8°C) until first use. Once in use, the pen can be stored at room temperature (up to 30°C) for the period mentioned in the product instructions (typically 28 days). Protect from direct light and heat. Do not freeze. Discard after the specified time, even if there is insulin left.
• **Travel Smart with Insulin:** When traveling, keep GLYCIPEN GLARITUS in your carry-on luggage. Never pack it in checked baggage, as temperature fluctuations can affect its efficacy. Bring a copy of your prescription and a letter from your doctor explaining your need for insulin. Always have extra supplies in case of unexpected delays.

• GLYCIPEN GLARITUS can be taken with or without food. Consistent timing of administration relative to meals is advisable to maintain stable blood sugar levels.
• Avoid excessive alcohol consumption while taking GLYCIPEN GLARITUS, as it can increase the risk of hypoglycemia (low blood sugar).
• Consult your doctor or diabetes educator for specific dietary recommendations tailored to your needs while on GLYCIPEN GLARITUS. They can provide guidance on carbohydrate intake, meal planning, and managing blood sugar levels effectively.